Patents Assigned to ANCHORED RSK3 INHIBITORS, LLC
  • COMPOSITIONS FOR TREATING HEART DISEASE BY INHIBITING THE ACTION OF mAKAP-beta
    Publication number: 20220143138
    Abstract: The present invention provides a method of protecting the heart from damage, by administering to a patient at risk of such damage, a pharmaceutically effective amount of a composition which inhibits the interaction of RSK3 and mAKAP?, or the expression or activity of one or both of those molecules. This composition may be in the form of a peptide that specifically inhibits mAKAP? binding to RSK3 or in the form of an siRNA construct which inhibits the expression of RSK3.
    Type: Application
    Filed: January 21, 2022
    Publication date: May 12, 2022
    Applicant: Anchored RSK3 Inhibitors, LLC
    Inventors: Michael S. KAPILOFF, Jinliang LI, Michael KRITZER
  • Compositions for treating heart disease by inhibiting the action of mAKAP?
    Patent number: 11229679
    Abstract: The present invention provides a method of protecting the heart from damage, by administering to a patient at risk of such damage, a pharmaceutically effective amount of a composition which inhibits the interaction of RSK3 and mAKAP?, or the expression or activity of one or both of those molecules. This composition may be in the form of a peptide that specifically inhibits mAKAP? binding to RSK3 or in the form of an siRNA construct which inhibits the expression of RSK3.
    Type: Grant
    Filed: April 1, 2020
    Date of Patent: January 25, 2022
    Assignee: ANCHORED RSK3 INHIBITORS, LLC
    Inventors: Michael S. Kapiloff, Jinliang Li, Michael Kritzer
  • COMPOSITIONS FOR TREATING HEART DISEASE BY INHIBITING THE ACTION OF mAKAP-beta
    Publication number: 20200289615
    Abstract: The present invention provides a method of protecting the heart from damage, by administering to a patient at risk of such damage, a pharmaceutically effective amount of a composition which inhibits the interaction of RSK3 and mAKAP?, or the expression or activity of one or both of those molecules. This composition may be in the form of a peptide that specifically inhibits mAKAP? binding to RSK3 or in the form of an siRNA construct which inhibits the expression of RSK3.
    Type: Application
    Filed: April 1, 2020
    Publication date: September 17, 2020
    Applicant: Anchored RSK3 Inhibitors, LLC
    Inventors: Michael S. KAPILOFF, Jinliang LI, Michael KRITZER
  • Compositions for treating heart disease by inhibiting the action of mAKAP-?
    Patent number: 10617737
    Abstract: The present invention provides a method of protecting the heart from damage, by administering to a patient at risk of such damage, a pharmaceutically effective amount of a composition which inhibits the interaction of RSK3 and mAKAP?, or the expression or activity of one or both of those molecules. This composition may be in the form of a peptide that specifically inhibits mAKAP? binding to RSK3 or in the form of an siRNA construct which inhibits the expression of RSK3.
    Type: Grant
    Filed: April 5, 2018
    Date of Patent: April 14, 2020
    Assignee: Anchored RSK3 Inhibitors, LLC
    Inventors: Michael S. Kapiloff, Jinliang Li, Michael Kritzer
  • COMPOSITIONS FOR TREATING HEART DISEASE BY INHIBITING THE ACTION OF mAKAP-ß
    Publication number: 20180296638
    Abstract: The present invention provides a method of protecting the heart from damage, by administering to a patient at risk of such damage, a pharmaceutically effective amount of a composition which inhibits the interaction of RSK3 and mAKAP?, or the expression or activity of one or both of those molecules. This composition may be in the form of a peptide that specifically inhibits mAKAP? binding to RSK3 or in the form of an siRNA construct which inhibits the expression of RSK3.
    Type: Application
    Filed: April 5, 2018
    Publication date: October 18, 2018
    Applicant: Anchored RSK3 Inhibitors, LLC
    Inventors: Michael S. KAPILOFF, Jinliang LI, Michael KRITZER, Catherine PASSARIELLO, Kimberly DODGE-KAFKA
  • Treatment of myocardial infarction by inhibiting the action of mAKAP?
    Patent number: 9937228
    Abstract: The present invention provides a method of protecting the heart from damage, by administering to a patient at risk of such damage, a pharmaceutically effective amount of a composition which inhibits the interaction of RSK3 and mAKAP?, or the expression or activity of one or both of those molecules. This composition may be in the form of a peptide that specifically inhibits mAKAP? binding to RSK3 or in the form of an siRNA construct which inhibits the expression of RSK3.
    Type: Grant
    Filed: August 7, 2015
    Date of Patent: April 10, 2018
    Assignee: ANCHORED RSK3 INHIBITORS, LLC
    Inventors: Michael S Kapiloff, Jinliang Li, Michael Kritzer, Catherine Passariello, Kimberly Dodge-Kafka
  • TREATMENT OF HEART DISEASE BY INHIBITION OF THE ACTION OF RIBOSOMAL S6 KINASE 3 (RSK3)
    Publication number: 20160038568
    Abstract: The present invention provides a method of protecting the heart from damage, by administering to a patient at risk of such damage, a pharmaceutically effective amount of a composition which inhibits the interaction of RSK3 and mAKAP?, or the expression or activity of one or both of those molecules. This composition may be in the form of a peptide that specifically inhibits mAKAP? binding to RSK3 or in the form of an siRNA construct which inhibits the expression of RSK3.
    Type: Application
    Filed: August 7, 2015
    Publication date: February 11, 2016
    Applicant: Anchored RSK3 Inhibitors, LLC
    Inventors: Michael S. KAPILOFF, Jinliang Li, Michael Kritzer, Catherine Passariello, Kimberly Dodge-Kafka
  • Treatment of heart disease by inhibition of the action of ribosomal S6 kinase 3 (RSK3)
    Patent number: 9132174
    Abstract: The present invention provides a method of protecting the heart from damage, by administering to a patient at risk of such damage, a pharmaceutically effective amount of a composition which inhibits the interaction of RSK3 and mAKAP?, or the expression or activity of one or both of those molecules. This composition may be in the form of a peptide that specifically inhibits mAKAP? binding to RSK3 or in the form of an siRNA construct which inhibits the expression of RSK3.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: September 15, 2015
    Assignee: Anchored RSK3 Inhibitors, LLC
    Inventors: Michael S Kapiloff, Jinliang Li, Michael Kritzer, Catherine Passariello, Kimberly Dodge-Kafka
  • TREATMENT OF HEART DISEASE BY INHIBITION OF THE ACTION OF RIBOSOMAL S6 KINASE 3 (RSK3)
    Publication number: 20140286928
    Abstract: The present invention provides a method of protecting the heart from damage, by administering to a patient at risk of such damage, a pharmaceutically effective amount of a composition which inhibits the interaction of RSK3 and mAKAP?, or the expression or activity of one or both of those molecules. This composition may be in the form of a peptide that specifically inhibits mAKAP? binding to RSK3 or in the form of an siRNA construct which inhibits the expression of RSK3.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 25, 2014
    Applicant: ANCHORED RSK3 INHIBITORS, LLC
    Inventors: Michael S. KAPILOFF, Jinliang LI, Michael KRITZER, Catherine PASSARIELLO, Kimberly DODGE-KAFKA